Clinical Trials Directory

Trials / Unknown

UnknownNCT00641433

Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails

Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Rosalind Franklin University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study's purpose is to prospectively determine whether topical therapy with an oxidized regenerated cellulose collagen-silver compound is more effective than the current standard of topical antibiotic therapy for care following the removal of an ingrown toenail. Eighty adult patients with ingrown toenails will be recruited. Each patient will randomly be assigned to apply either topical silver sulfadiazine cream (standard antibiotic) or the novel collagen-silver compound to their nail bed daily, following removal of the ingrown portion of nail. Patients will return for follow up visits weekly, until healing has occurred or twelve weeks have passed. Healing will be defined as resolution of drainage and inflammatory changes surrounding the nail border.

Conditions

Interventions

TypeNameDescription
DEVICEoxidized regenerated cellulose collagen-silverWound dressed daily with oxidized regenerated cellulose collagen-silver matrix.
DRUGtopical silver sulfadiazine creamCream will be applied to nailbed daily and dressed with a bandage until healing occurs.

Timeline

Start date
2005-11-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2008-03-24
Last updated
2008-03-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00641433. Inclusion in this directory is not an endorsement.